Helmut Salih

29PUBLICATIONS
92CO-AUTHORS
Medical infection agents (incl. prions)GlycoconjugatesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Sep 30, 2024
Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurin.

Frank G Rücker, Lars Bullinger, Sibylle Cocciardi

|Apr 13, 2024
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome.

Anna Seller, Christian M Tegeler, Jonas Mauermann

|Mar 06, 2024
Immunocytokines with target cell-restricted IL-15 activity for treatment of B cell malignancies.

Latifa Zekri, Ilona Hagelstein, Melanie Märklin

|Nov 18, 2023
TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification.

Naomi Hoenisch Gravel, Annika Nelde, Jens Bauer

|Oct 17, 2023
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells.

Annika Nelde, Heiko Schuster, Jonas S Heitmann

|Sep 09, 2023
Targeting NKG2DL with Bispecific NKG2D-CD16 and NKG2D-CD3 Fusion Proteins on Triple-Negative Breast Cancer.

Polina Kaidun, Samuel J Holzmayer, Sarah M Greiner

Pageof 5